Michael Hassett, MD, MPH, discusses the rise of oral therapeutics in breast cancer care, emphasizing patient support, education, and overcoming financial barriers for better outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback